Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02142543 · ClinicalTrials.gov registry record · Early Phase 1
The Effect of 2-DeNT Oral Topical Powder on Minor Recurrent Aphthous Ulcer
A Early Phase 1 study of Minor Recurrent Aphthous Stomatitis Lesions, sponsored by Texas A&M University.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 23
- Enrollment target
- 1
- Study location
NCT02142543 is a Early Phase 1 study of Minor Recurrent Aphthous Stomatitis Lesions that has completed, run by Texas A&M University. The registered enrollment target is 23 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02142543, a Early Phase 1 study of Minor Recurrent Aphthous Stomatitis Lesions, has completed, sponsored by Texas A&M University.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 23 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective, randomized, blinded, placebo-controlled, crossover clinical trial to evaluate the efficacy of 2-DeNT oral topical powder in the treatment of recurrent aphthous stomatitis (RAS). To be included in the study, subjects must have had minor RAS ulcers of less than 48 hours duration. It was randomly determined which powder was used first; all subjects used both the 2-DeNT powder and the placebo powder. Subjects applied the powder twice daily and maintained a daily log recording the size of the ulcer, its erythema score, and their level of pain. The subjects continued applying the 2-DeNT powder until the ulcer was resolved.
Conditions Studied
Interventions
- DRUG Placebo Comparator
- DRUG 2-DeNT powder
Study Locations (1)
Texas
- Texas A&M Baylor College of Dentisry - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2012-03 |
| Est. Completion | 2012-12 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02142543
The ClinicalTrials.gov registry entry for NCT02142543 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Texas A&M University, which has 95 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Minor Recurrent Aphthous Stomatitis Lesions appearing as the primary indexed condition, and to 2 interventions - of which Placebo Comparator is the first listed.
NCT02142543 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT02142543 about?
NCT02142543 is a clinical study titled "The Effect of 2-DeNT Oral Topical Powder on Minor Recurrent Aphthous Ulcer". This is a prospective, randomized, blinded, placebo-controlled, crossover clinical trial to evaluate the efficacy of 2-DeNT oral topical powder in the treatment of recurrent aphthous stomatitis (RAS). To be included in the study, subjects must have had minor RAS ulcers of less than 48 hours duration...
What is the current status of trial NCT02142543?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 23 participants. The study started on 2012-03. Estimated completion is 2012-12.
What conditions does trial NCT02142543 study?
This clinical trial studies the following conditions: Minor Recurrent Aphthous Stomatitis Lesions.
What interventions are being tested in trial NCT02142543?
The interventions under investigation include: Placebo Comparator (DRUG), 2-DeNT powder (DRUG).
Who is sponsoring clinical trial NCT02142543?
This trial is sponsored by Texas A&M University, which has 95 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02142543 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.